Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |